Related Experiment Video
Updated: Dec 20, 2025

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Immunogenicity of Protein Therapeutics: A Lymph Node Perspective
Kristy Fu1, Kylie March1, Aikaterini Alexaki2
1Tissue Analysis Core, Immunology Laboratory, Vaccine Research Center, NIAID, National Institutes of Health (NIH), Bethesda, MD, United States.
Protein therapeutics face immunogenicity challenges due to antibody development. Understanding adaptive immunity cell roles in antibody responses can reduce this, improving therapeutic efficacy.
Area of Science:
- Molecular biology
- Protein engineering
- Immunology
Background:
- Advancements in protein therapeutics allow for complex *in vivo* administration.
- Therapeutic immunogenicity, leading to antibody development, limits their clinical use.
- Antibody responses are critical for pathogen defense and occur in secondary lymphoid organs.
Purpose of the Study:
- To explore the cellular and molecular mechanisms behind antibody responses to protein therapeutics.
- To identify strategies for reducing therapeutic immunogenicity and enhancing efficacy.
Main Methods:
- Focus on the role of adaptive immunity cells, specifically follicular helper CD4 T cells and germinal center B cells.
- Investigating the anatomical sites of antibody response generation, including B cell follicles and germinal centers.
Main Results:
- Highlighting the importance of coordinated adaptive immunity cell function in generating antibody responses.
- Identifying key cellular players and anatomical locations involved in immune reactions to therapeutics.
Conclusions:
- Understanding immune mechanisms against therapeutics is key to overcoming immunogenicity.
- Novel strategies can be developed to improve the safety and effectiveness of protein therapeutics.
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

